SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Mylotte JM. Measuring antibiotic use in a long-term care facility. Am J Infect Control. 1996;24: 1749.
  • 2
    Montgomery P, Semenchuk M, Nicolle LE. Antimicrobial use in nursing homes in Manitoba. J Geriatr Drug Ther. 1995;9: 5574.
  • 3
    Warren JW, Palumbo FB, Fitterman L, Speedie SM. Incidence and characteristics of antibiotic use in aged nursing home patients. J Am Geriatr Soc. 1991;39: 96372.
  • 4
    Katz PR, Beam TR, Brand F, Boyce K. Antibiotic use in the nursing home. Physician practice patterns. Arch Intern Med. 1990;150: 14658.
  • 5
    Smith PW. Nursing home infection control: a status report. Infect Control Hosp Epidemiol. 1998;19: 3669.
  • 6
    Goldmann DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA. 1996;275: 23440.
  • 7
    Armstrong-Evans M, Litt M, McArthur MA, et al. Control of transmission of vancomycin-resistant Enterococcus faecium in a long-term-care facility. Infect Control Hosp Epidemiol. 1999;20: 3127.
  • 8
    Greenaway CA & Miller MA. Lack of transmission of vancomycin-resistant enterococci in three long-term-care facilities. Infect Control Hosp Epidemiol. 1999;20: 3413.
  • 9
    Wiener J, Quinn JP, Bradford PA, et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA. 1999;281: 51723.
  • 10
    Terpenning MS, Bradley SF, Yan JY, Chenoweth CE, Jorgensen KA, Kauffman CA. Colonization and infection with antibiotic-resistance bacteria in a long-term care facility. J Am Geriatr Soc. 1994;42: 10629.
  • 11
    Wingard E, Shlaes JH, Mortimer EA, Shlaes DM. Colonization and cross-colonization of nursing home patients with trimethoprim-resistant gram-negative bacilli. Clin Infect Dis. 1993;16: 7581.
  • 12
    Chenoweth CE, Bradley SF, Terpenning MS, et al. Colonization and transmission of high-level gentamicin-resistant enterococci in a long-term care facility. Infect Control Hosp Epidemiol. 1994;15: 7039.
  • 13
    Gaynes RP, Weinstein RA, Chamberlin W, Kabins SA. Antibiotic-resistant flora in nursing home patients admitted to the hospital. Arch Intern Med. 1985;145: 8047.
  • 14
    Rice LB, Willey SH, Papanicolaou GA, et al. Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother. 1990;34: 21939.
  • 15
    Muder RR, Brennen C, Goetz AM, Wagener MM, Rihs JD. Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs medical center. Antimicrob Agents Chemother. 1991;35: 2568.
  • 16
    Nicolle LE, Bentley D, Garibaldi R, Neuhaus E, Smith P. Antimicrobial use in long-term care facilities. Infect Control Hosp Epidemiol. 1996;17: 11928.
  • 17
    Nicolle LE, Strausbaugh LJ, Garibaldi RA. Infections and antibiotic resistance in nursing homes. Clin Microbiol Rev. 1996;9: 117.
  • 18
    Strausbaugh LJ & Joseph C. In: MayhallCG, ed. Hospital Epidemiology and Infection Control. Baltimore, Md: Williams and Wilkins; 1996: 115170.
  • 19
    Zimmer JG, Bentley DW, Valenti WM, Watson NM. Systemic antibiotic use in nursing homes. A quality assessment. J Am Geriatr Soc. 1986;34: 70310.
  • 20
    Jones SR, Parker DF, Liebow ES, Kimbrough RC, Frear RS. Appropriateness of antibiotic therapy in long-term care facilities. Am J Med. 1987;83: 499502.
  • 21
    McGeer A, Campbell B, Emori TG, et al. Definitions of infection for surveillance in long-term care facilities. Am J Infect Control. 1991;19: 17.
  • 22
    Chambers LW, Labelle R, Gafni A, Goeree R. The Organization and Financing of Public and Private Sector Long Term Care Facilities for the Elderly in Canada, Chapter 6: Ontario Report. McMaster University Centre for Health Economics and Policy Analysis Working Paper 928; 1992. .
  • 23
    Nicolle LE. Asymptomatic bacteriuria in the elderly. Infect Dis Clin North Am. 1997;11: 64762.
  • 24
    Nicolle LE, Bjornson J, Harding GK, MacDonnel JA. Bacteriuria in elderly institutionalized men. N Engl J Med. 1983;309: 14205.
  • 25
    Nicolle LE, Mayhew JW, Bryan L. Prospective randomized comparison of therapy and no therapy for asymptomatic bacteriuria in institutionalized elderly women. Am J Med. 1987;83: 2733.
  • 26
    Ouslander JG, Schapira JF, Schnelle JF, et al. Does eradicating bacteriuria affect the severity of chronic urinary incontinence in nursing home residents? Ann Intern Med. 1995;122: 74954.
  • 27
    Abrutyn E, Mossey J, Berlin JA, et al. Does asymptomatic bacteriuria predict mortality and does antimicrobial treatment reduce mortality in elderly ambulatory women. Ann Intern Med. 1994;120: 82733.
  • 28
    Garner JS, Bennett JV, Schechler WE, et al. Surveillance of nosocomial infections. In: BrachmanPS, EichhoffTC, eds. Proceedings of the International Conference on Nosocomial Infections. Chicago: American Hospital Association; 1971.
  • 29
    Muder RR. Pneumonia in residents of long-term care facilities: epidemiology, etiology, management, and prevention. Am J Med. 1998;105: 31930.DOI: 10.1016/s0002-9343(98)00262-9
  • 30
    Scully BE. Therapy of respiatory tract infections with quinolone antimicrobial agents. In: HooperDC, WolfsonJS, eds. Quinolone Antimicrobial Therapy. 2nd ed. Washington, DC: American Society for Microbiology; 1993.
  • 31
    Chen DK, McGeer A, De Azavedo JC, Low DE. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N Engl J Med. 1999;341: 2339.